204 related articles for article (PubMed ID: 16596171)
1. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Mizobe T; Ishibashi N; Mori S; Akagi Y; Ikeda S; Ozasa H; Murakami H; Shirouzu K
Oncol Rep; 2006 May; 15(5):1111-6. PubMed ID: 16596171
[TBL] [Abstract][Full Text] [Related]
2. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Sasatomi T; Ishibashi N; Ohkita A; Mizobe T; Ogo S; Ikeda S; Ozasa H; Shirouzu K
Cancer Chemother Pharmacol; 2006 May; 57(5):577-83. PubMed ID: 16133529
[TBL] [Abstract][Full Text] [Related]
3. Oral fluoropyrimidines may not reduce the risk of postoperative recurrence in colorectal cancer associated with mesenteric lymph node metastasis.
Ogata Y; Torigoe S; Matono K; Sasatomi T; Ishibashi N; Shida S; Ohkita A; Fukumitu T; Mizobe T; Ikeda S; Ogo S; Ozasa H; Shirouzu K
Int Surg; 2007; 92(6):314-9. PubMed ID: 18402123
[TBL] [Abstract][Full Text] [Related]
4. The benefit of post-operative adjuvant chemotherapy using oral fluoropyrimidines in rectal cancer.
Ogata Y; Matono K; Torigoe S; Mizobe T; Sasatomi T; Ishibashi N; Shida S; Ohkita A; Fukumitu T; Ikeda S; Ogo S; Ozasa H; Shirouzu K
Kurume Med J; 2005; 52(1-2):1-7. PubMed ID: 16119607
[TBL] [Abstract][Full Text] [Related]
5. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
8. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer.
Chin KF; Greenman J; Gardiner E; Kumar H; Topping K; Monson J
Br J Cancer; 2000 Dec; 83(11):1425-31. PubMed ID: 11076648
[TBL] [Abstract][Full Text] [Related]
10. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205.
Shimada Y; Hamaguchi T; Mizusawa J; Saito N; Kanemitsu Y; Takiguchi N; Ohue M; Kato T; Takii Y; Sato T; Tomita N; Yamaguchi S; Akaike M; Mishima H; Kubo Y; Nakamura K; Fukuda H; Moriya Y
Eur J Cancer; 2014 Sep; 50(13):2231-40. PubMed ID: 24958736
[TBL] [Abstract][Full Text] [Related]
11. Using preoperative UFT to predict sensitivity to fluoropyrimidines in colorectal cancer.
Fujii M
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):55-60. PubMed ID: 10442363
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
13. Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer.
Nakagoe T; Ishikawa H; Sawai T; Tuji T; Ayabe H; Eida K; Nogawa T; Nakamura Y; Kunisaki T; Tobinaga K; Furukawa M; Ino M
Anticancer Res; 2000; 20(2B):1069-75. PubMed ID: 10810399
[TBL] [Abstract][Full Text] [Related]
14. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.
Fondevila C; Metges JP; Fuster J; Grau JJ; Palacín A; Castells A; Volant A; Pera M
Br J Cancer; 2004 Jan; 90(1):206-15. PubMed ID: 14710231
[TBL] [Abstract][Full Text] [Related]
15. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
Ohwada S; Ikeya T; Yokomori T; Kusaba T; Roppongi T; Takahashi T; Nakamura S; Kakinuma S; Iwazaki S; Ishikawa H; Kawate S; Nakajima T; Morishita Y
Br J Cancer; 2004 Mar; 90(5):1003-10. PubMed ID: 14997197
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
Hong KD; Lee SI; Moon HY
Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
[TBL] [Abstract][Full Text] [Related]
20. Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer.
Chen TC; Jeng YM; Liang JT
J Formos Med Assoc; 2021 May; 120(5):1194-1201. PubMed ID: 33023787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
